Cumulative live birth rates in a freeze-all or fresh transfer strategy after one complete ART cycle in ovulatory women: secondary outcome of a randomised controlled trial

S Stormlund,N Sopa,A Zedeler,J Bogstad,L Prætorius,HS Nielsen,A Klajnbard,ALM Englund,M Laczna Kitlinski,N la Cour Freiesleben,NP Polyzos,C Bergh,P Humaidan,A Nyboe Andersen,K Løssl,A Pinborg
DOI: https://doi.org/10.1016/j.rbmo.2024.104449
IF: 4.567
2024-09-15
Reproductive BioMedicine Online
Abstract:RESEARCH QUESTION Are the cumulative live birth rates following a freeze-all strategy compared with a fresh transfer strategy including all subsequent frozen-thaw cycles from the same oocyte retrieval similar? DESIGN Secondary outcome in a multicentre randomised controlled trial including 460 women allocated in a 1:1 ratio to (1)Freeze-all strategy including GnRH agonist trigger and single vitrified-warmed blastocyst transfer in a subsequent modified-natural FET cycle or (2)Fresh transfer strategy with hCG trigger and single blastocyst in the fresh cycle. Women were recruited over a 2-year period from May 2016 to September 2018. The minimum follow-up time from the start of ovarian stimulation was 2 years. RESULTS Baseline and treatment-related characteristics were similar between the two groups and equal number of patients had additional frozen-thawed embryo transfers following the initial fresh or frozen transfer in the two groups. Combining all fresh and frozen transfers from the included oocyte retrieval, the cumulative live birth rate was 42.6% (95/223) in the Freeze-all group versus 41.7% (96/230) in the Fresh strategy group (risk ratio (RR): 1.0;95% CI: 0.87-1.19, P=0.93). The mean time to the first pregnancy was 125.8±60.8 versus 82.74 ± 85.9 days in the Freeze all and Fresh transfer group, respectively. The total number of deliveries from all subsequent FET cycles was similar between the freeze all strategy and fresh transfer strategy group, respectively: 15.2%(34/223) versus 12.6%(29/239), p=0.5. CONCLUSIONS When comparing a freeze-all strategy with a fresh transfer strategy we find no significant difference in cumulative live birth rates between the two strategies in a randomised controlled trial setting.
obstetrics & gynecology,reproductive biology
What problem does this paper attempt to address?